Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic – BIBY-I study (observations lasting 3 to 12 months)
2013
Abstract
BIBY study objective: To obtain experience with exenatide treatment (Byetta) in patients with diabetes mellitus type 2 in a common clinical practice of diabetology departments. Type of observation: Observational study conducted by a randomly selected group of outpatient medical practitioners from 28 diabetology departments in the Czech Republic.
Observed and assessed population: 465 patients underwent at least three months of Byetta treatment; 347 persons (74.6% of the research population) stayed for the extended observation of 6–12 months.